Suppr超能文献

人类肝细胞癌中抗原组的异质性。

Heterogeneity of antigenic constellation in human hepatocellular carcinoma.

作者信息

Ceausu Mihai, Socea Bogdan, Serban Dragos, Smarandache Cătălin Gabriel, Predescu Dragoş, Bacalbaşa Nicolae, Slavu Iulian, Tulin Adrian, Alecu Lucian, Ceauşu Zenaida

机构信息

Department of Pathology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Department of Surgery, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.

出版信息

Exp Ther Med. 2021 Mar;21(3):270. doi: 10.3892/etm.2021.9701. Epub 2021 Jan 25.

Abstract

Hepatocellular carcinoma is one of the primary liver malignancies responsible for over a million deaths per year worldwide (approximately 10% of all deaths in the adult age range). The diagnosis of HCC can be difficult and often requires the use of more than one microscopic technique. A retrospective study was performed on a study batch of 42 cases that died of HCC due to metastasis or other secondary complications. Tissue samples were taken in order to investigate the tumour antigenic constellation by means of IHC method using a large variety of antibodies. hybridization was also performed for albumin mRNA to assess the albumin expression in some selected cases. Telomerase activity was investigated using IHC method for the hTERT catalytic subunit. A cocktail of hepatic cytokeratins (CK8, 18) combined with Hep Par-1 and associated to albumin proved to be more powerful than albumin alone in differentiating HCC and increased the value of tumour diagnosis. hTERT expression was proportionally reverse to the tumour degree of differentiation, but was independent from the expression of tumour-proliferating indexes. The heterogeneity of the antigenic constellation in hepatocellular carcinoma suggests an antigenic mosaicism, which can be expressed a synchronous or metachronous manner, depending on the tumour degree of differentiation.

摘要

肝细胞癌是主要的肝脏恶性肿瘤之一,每年在全球导致超过100万人死亡(约占成年年龄段所有死亡人数的10%)。肝细胞癌的诊断可能具有挑战性,通常需要使用不止一种显微技术。对一组42例因转移或其他继发并发症死于肝细胞癌的病例进行了回顾性研究。采集组织样本,以便使用多种抗体通过免疫组化方法研究肿瘤抗原组合。还对部分选定病例进行白蛋白mRNA杂交,以评估白蛋白表达情况。使用免疫组化方法对hTERT催化亚基研究端粒酶活性。一组肝细胞角蛋白(CK8、18)联合Hep Par-1并与白蛋白相关,在鉴别肝细胞癌方面比单独使用白蛋白更有效,提高了肿瘤诊断价值。hTERT表达与肿瘤分化程度呈反比,但与肿瘤增殖指数的表达无关。肝细胞癌抗原组合的异质性提示抗原镶嵌现象,其可根据肿瘤分化程度以同步或异时方式表现出来。

相似文献

1
6
Telomerase and c-myc expression in hepatocellular carcinomas.端粒酶与c-myc在肝细胞癌中的表达
Eur J Surg Oncol. 2004 May;30(4):384-90. doi: 10.1016/j.ejso.2004.01.003.

引用本文的文献

1
An Update of Immunohistochemistry in Hepatocellular Carcinoma.肝细胞癌免疫组织化学的最新进展
Diagnostics (Basel). 2025 Aug 25;15(17):2144. doi: 10.3390/diagnostics15172144.
6
Measuring HCC Tumor Size in MRI-The Sequence Matters!在MRI中测量肝癌肿瘤大小——序列很重要!
Diagnostics (Basel). 2021 Oct 28;11(11):2002. doi: 10.3390/diagnostics11112002.

本文引用的文献

2
Hepatocellular carcinoma: Mechanisms of progression and immunotherapy.肝细胞癌:进展机制与免疫治疗。
World J Gastroenterol. 2019 Jul 7;25(25):3151-3167. doi: 10.3748/wjg.v25.i25.3151.
7
CD34, PCNA and CK19 expressions in AFP- hepatocellular carcinoma.CD34、PCNA 和 CK19 在 AFP- 肝细胞癌中的表达。
Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5200-5205. doi: 10.26355/eurrev_201808_15717.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验